EUVIMEDEUVIMED entdecken
Multizentrische Studie

Ten-year of French multicentric experience in the management of peritoneal mesothelioma with 924 patients

Barbara Noiret, Xavier Lenne, Guillaume Piessen, Olivia Sgarbura, Amelie Bruandet, Vahan Kepenekian, Clarisse Eveno

European Journal of Surgical Oncology · 2026-04 · 52 (4) · 111492

DOI: 10.1016/j.ejso.2026.111492 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift European Journal of Surgical Oncology, 2026-04. Verfasst von Barbara Noiret und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, F-59000, Lille, France. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Hyperthermic Intraperitoneal Chemotherapy, Cytoreduction Surgical Procedures, Mesothelioma, Malignant. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Diffuse malignant peritoneal mesothelioma (DMPM) is a rare disease for which only selected patients are eligible for cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). The aim of our study was to evaluate oncologic outcomes of different treatments patterns of DMPM at national level. METHODS: All patients treated for DMPM between 2012 and 2021 in France were extracted through a national administrative database. Perioperative outcomes were analyzed into 3 groups: upfront-resectable, borderline-resectable (B-R) and inoperable patients. Survival outcomes were performed by Kaplan-Meier method. A multivariate logistic model was used to identify factors affecting survival. RESULTS: Of 924 patients, 270, 117 and 537 were identified as upfront-resectable, B-R and inoperable patients. The median age was 53 years with a mean Elixhauser comorbidity index of 3.2. Patients treated with CRS-HIPEC were younger with less comorbidities and had more exploratory laparoscopy compared to inoperable patients (p < 0.001). Majority of surgical patients were mostly treated in expert centers (97.7%). 90-day postoperative mortality (POM) was 2.1%. Major morbidity (MM) occurred in 50.9% with a failure-to-rescue (FTR) rate of 4.1%. Upfront-resectable patients had significantly better 5-year survival compared to B-R and inoperable patients (84.6% vs 55% vs 12.9%, p < 0.0001). After multivariate analysis, male gender (p < 0.0001), age (p = 0.005), B-R group (p < 0.0001), MM (p = 0.003) and adjuvant chemotherapy (p = 0.01) were independently associated with decrease 5-year survival. CONCLUSION: CRS and HIPEC is a safe procedure with a low 90-day POM and FTR. Patients should be address to expert centers to evaluate patients that could benefit from curative strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal NeoplasmsHyperthermic Intraperitoneal ChemotherapyCytoreduction Surgical ProceduresMesothelioma, MalignantMesotheliomaLung NeoplasmsHumansMaleMiddle AgedFemaleFranceAgedAdultSurvival RateRetrospective StudiesLaparoscopy

Autor:innen und Institutionen

  • Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, F-59000, Lille, France.
  • Department of Medical Information, Lille University Hospital, Lille, France.
  • Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, F-59000, Lille, France; UMR-S1277 - CANTHER laboratory "Cancer Heterogeneity, Plasticity and Resistance to Therapies", Lille, France.
  • Department of Surgical Oncology, Cancer Institute Montpellier, University of Montpellier, France; IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM U1194, Université de Montpellier, Montpellier, F-34298…
  • Surgical Oncology Department, Hôpital Lyon Sud, Hospices Civils de Lyon, 69495, Pierre Bénite, France; CICLY-EA3738, Université Claude Bernard Lyon I (UCBL1), 69622, Lyon, France.
  • Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, F-59000, Lille, France; UMR-S1277 - CANTHER laboratory "Cancer Heterogeneity, Plasticity and Resistance to Therapies", Lille, France. E…

Zitieren

APA

Noiret, B., Lenne, X., Piessen, G., Sgarbura, O., Bruandet, A., Kepenekian, V., & Eveno, C. (2026). Ten-year of French multicentric experience in the management of peritoneal mesothelioma with 924 patients. European Journal of Surgical Oncology, 52(4), 111492. https://doi.org/10.1016/j.ejso.2026.111492

Vancouver

Noiret B, Lenne X, Piessen G, Sgarbura O, Bruandet A, Kepenekian V, et al. Ten-year of French multicentric experience in the management of peritoneal mesothelioma with 924 patients. European Journal of Surgical Oncology. 2026;52(4):111492. doi:10.1016/j.ejso.2026.111492

BibTeX
@article{Noiret2026,
  author = {Noiret, Barbara and Lenne, Xavier and Piessen, Guillaume and Sgarbura, Olivia and Bruandet, Amelie and Kepenekian, Vahan and Eveno, Clarisse},
  title = {Ten-year of French multicentric experience in the management of peritoneal mesothelioma with 924 patients},
  journal = {European Journal of Surgical Oncology},
  year = {2026},
  volume = {52},
  number = {4},
  pages = {111492},
  doi = {10.1016/j.ejso.2026.111492}
}
Kostenlos starten →